The EHA2023 Hybrid Congress offers you an interactive, comprehensive program dedicated to clinical research and practice, basic and translational research, as well as important opportunities for collaboration with stakeholders in the field of hematology. The educational and scientific program will highlight state-of-the-art clinical practice, the latest findings in hematology research, and recent approaches on the diagnosis and treatment of hematologic diseases.
EHA is excited to welcome you live in Frankfurt, Germany from June 8-11, 2023. EHA2023 will also be live stream on the Congress platform from June 8-11, 2023. Then the EHA2023 Congress continues on virtually exclusively on the Congress platform during the virtual days from June 14-15, 2023. The Congress platform will be open until August 15, 2023.
Please note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session at the time assigned by the Scientific Program Committee (SPC). We, therefore, recommend that submitter of an abstract registers for the Congress. The terms & conditions of the EHA2023 abstract submission can be found here.
The abstracts submitted via the regular submission process will be reviewed and allocated by the international panel of reviewers and the SPC. The authors will be informed about the allocation latest by April 24, 2023. Should you have any questions regarding the abstract submission or terms, please contact eha-abstracts@interplan.de.
The publication date of accepted abstracts is May 11, 2023 (16:00 CEST). A list of deadlines and important dates can be found here, as well as below.